This is a skilled care platform providing both home health and hospice services, with the founder still involved at the ownership level and a CEO managing day-to-day operations. The business serves a steady patient base of approximately 80–110 home health clients and 75–82 hospice clients, supported by a lean office team and mostly field-based clinical workforce. Revenue has reportedly held around $5.1M–$5.3M from 2023–2025, with 2026 projected at $6.0M–$6.3M. Adjusted EBITDA for 2025 was described at roughly $1.2M–$1.3M, with typical margins in the 20%–25% range. The opportunity is interesting because the company appears to have strong referral momentum, limited formal marketing infrastructure, and room to expand census through stronger recruiting, sales, and patient acquisition systems.